Bending Spoons S.p.A BSP
$41.05 −$0.65 (-1.56%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $41.14 +0.23%
Open$41.79
Prev close$41.70
Day range$40.55 – $45.16
Volume5.87M
Market cap$26.08B
P/E (TTM)103.9
Dividend yield–
BSP Stock News
Headlines matching Bending Spoons S.p.A or the BSP ticker, most recent first.
- BTIG Downgrades Franklin BSP Realty Trust(FBRT.US) to Hold Rating Negative
- Goldman Sachs Maintains Bending Spoons S.p.A(BSP.US) With Buy Rating, Maintains Target Price $50
- Press Release: Franklin BSP Realty Trust, Inc. Announces Third Quarter 2026 Dividends and Reauthorization of $50 Million Share Repurchase Program
- Evercore Maintains Bending Spoons S.p.A(BSP.US) With Hold Rating, Raises Target Price to $40 Positive
- Analysts' Opinions Are Mixed on These NA Stocks: Omada Health, Inc. (OMDA), Bending Spoons (BSP) and Graphic Packaging (GPK)
- Wells Fargo Maintains Bending Spoons S.p.A(BSP.US) With Buy Rating, Raises Target Price to $48 Positive
- Analysts Offer Insights on NA Companies: Bending Spoons (BSP), EquipmentShare.com, Inc. (EQPT) and BitGo Holdings, Inc. Class A (BTGO)
- Goldman Sachs Maintains Bending Spoons S.p.A(BSP.US) With Buy Rating, Raises Target Price to $50 Positive
- Wells Fargo Maintains Bending Spoons S.p.A(BSP.US) With Buy Rating, Maintains Target Price $45
- Mizuho Securities Maintains Bending Spoons S.p.A(BSP.US) With Buy Rating, Cuts Target Price to $72 Negative
- Analysts Conflicted on These NA Names: Bending Spoons (BSP), Alliance Laundry Holdings, Inc. (ALH) and Omada Health, Inc. (OMDA)
- BofA Securities Maintains Bending Spoons S.p.A(BSP.US) With Sell Rating, Maintains Target Price $39
- BofA Securities Downgrades BENDING SPOONS S.P.A(BSP.US) to Sell Rating, Raises Target Price to $39 Mixed
- Analysts Have Conflicting Sentiments on These NA Companies: Bending Spoons (BSP), EToro (ETOR) and Bicara Therapeutics Inc. (BCAX)
- Mizuho Securities Maintains BENDING SPOONS S.P.A(BSP.US) With Buy Rating, Raises Target Price to $72.28 Positive
No comments yet — be the first to weigh in on BSP.
Sign in to join the discussion.